Forte Biosciences (FBRX) Change in Account Payables (2016 - 2020)
Forte Biosciences (FBRX) has disclosed Change in Account Payables for 5 consecutive years, with $25000.0 as the latest value for Q4 2020.
- Quarterly Change in Account Payables fell 96.64% to $25000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$369000.0 through Dec 2020, down 137.81% year-over-year, with the annual reading at $5.5 million for FY2025, 83.48% up from the prior year.
- Change in Account Payables for Q4 2020 was $25000.0 at Forte Biosciences, up from -$1.4 million in the prior quarter.
- The five-year high for Change in Account Payables was $3.1 million in Q3 2018, with the low at -$1.4 million in Q3 2020.
- Average Change in Account Payables over 5 years is $137850.0, with a median of $50500.0 recorded in 2016.
- The sharpest move saw Change in Account Payables surged 8873.53% in 2018, then tumbled 1352.78% in 2020.
- Over 5 years, Change in Account Payables stood at -$278000.0 in 2016, then soared by 389.21% to $804000.0 in 2017, then plummeted by 237.69% to -$1.1 million in 2018, then skyrocketed by 167.21% to $744000.0 in 2019, then crashed by 96.64% to $25000.0 in 2020.
- According to Business Quant data, Change in Account Payables over the past three periods came in at $25000.0, -$1.4 million, and $1.9 million for Q4 2020, Q3 2020, and Q2 2020 respectively.